Old Web
English
Sign In
Acemap
>
Paper
>
Preclinical profile of MDL 100 907, a potent and selective 5-HT2A antagonist in development for schizophrenia
Preclinical profile of MDL 100 907, a potent and selective 5-HT2A antagonist in development for schizophrenia
1996
Stephen M. Sorensen
Albert A. Carr
P.L.M. van Giersbergen
Janice M. Hitchcock
John H. Kehne
Christopher J. Schmidt
Keywords:
Neuroscience
Antagonist
Schizophrenia
Psychiatry
Psychology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]